Yasuyuki Kojima Selected Research

Drug Combinations

1/2023	Doublet or Triplet Antiemetic Prophylaxis for Nausea and Vomiting Induced by Trastuzumab Deruxtecan: an Open-Label, Randomized, and Multicenter Exploratory Phase 2 Study.
1/2021	Antiemetic Efficacy of Adding Olanzapine 5 mg to Aprepitant, Palonosetron and Dexamethasone-Sparing After Day Two for Cancer Patients Receiving Anthracycline and Cyclophosphamide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasuyuki Kojima Research Topics

Disease

25	Breast Neoplasms (Breast Cancer) 04/2024 - 06/2008
24	Neoplasms (Cancer) 03/2024 - 10/2003
5	Triple Negative Breast Neoplasms 09/2021 - 01/2016
4	Neoplasm Metastasis (Metastasis) 07/2020 - 02/2015
3	Carcinoma (Carcinomatosis) 07/2022 - 01/2008
3	Hypertension (High Blood Pressure) 12/2011 - 08/2008
2	Nausea 01/2023 - 01/2021
2	Vomiting 01/2023 - 01/2021
2	Lymphatic Metastasis 01/2022 - 01/2020
2	Cardiotoxicity 01/2022 - 12/2019
2	Meningeal Carcinomatosis 07/2020 - 07/2020
2	Renal Cell Carcinoma (Grawitz Tumor) 11/2011 - 10/2003
2	Adenocarcinoma 01/2010 - 10/2005
1	Lobular Carcinoma 01/2024
1	Disease Progression 12/2023
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2023
1	Carcinogenesis 12/2023
1	Peripheral Nervous System Diseases (PNS Diseases) 09/2021
1	Hypersensitivity (Allergy) 09/2021
1	Pathologic Complete Response 05/2021
1	Anorexia 01/2021
1	Fatigue 01/2021
1	Brain Neoplasms (Brain Tumor) 07/2020
1	Leiomyoma (Uterine Fibroids) 07/2015
1	Fibroadenoma 07/2015
1	Albuminuria 12/2011
1	Proteinuria 12/2011

Drug/Important Bio-Agent (IBA)

7	human ERBB2 proteinIBA 09/2021 - 09/2016
6	Trastuzumab (Herceptin)FDA Link 01/2022 - 09/2016
6	taxaneIBA 09/2021 - 09/2016
4	AnthracyclinesIBA 01/2021 - 09/2016
3	Proteins (Proteins, Gene)FDA Link 12/2023 - 06/2008
3	ErbB Receptors (EGF Receptor)IBA 01/2022 - 12/2018
3	Phenobarbital (Luminal)FDA Link 09/2021 - 01/2016
3	eribulin FDA Link 05/2020 - 10/2019
3	Estrogen ReceptorsIBA 01/2020 - 01/2016
3	Biomarkers (Surrogate Marker)IBA 12/2019 - 08/2008
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2023 - 08/2015
2	AntiemeticsIBA 01/2023 - 01/2021
2	Drug CombinationsIBA 01/2023 - 01/2021
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023 - 01/2021
2	Albumin-Bound Paclitaxel FDA Link 09/2021 - 10/2018
2	Ethanol (Ethyl Alcohol)IBA 09/2021 - 10/2003
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 10/2018
2	Hormones (Hormone)IBA 11/2020 - 09/2009
2	pertuzumabIBA 05/2020 - 01/2020
2	Fluorouracil (Carac)FDA LinkGeneric 01/2019 - 10/2018
2	PKC-3 proteinIBA 09/2014 - 09/2009
2	Cadherins (E-Cadherin)IBA 09/2014 - 01/2010
2	PotassiumIBA 12/2011 - 01/2010
2	CreatinineIBA 12/2011 - 11/2003
2	protein kinase C lambdaIBA 01/2010 - 06/2008
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2023
1	PlatinumIBA 12/2023
1	Cell-Free Nucleic AcidsIBA 12/2023
1	Poly Adenosine Diphosphate RiboseIBA 12/2023
1	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 01/2023
1	trastuzumab deruxtecanIBA 01/2023
1	Neurokinin-1 Receptor AntagonistsIBA 01/2023
1	cremophorIBA 09/2021
1	Olanzapine (Zyprexa)FDA Link 01/2021
1	SteroidsIBA 01/2021
1	Palonosetron (Aloxi)FDA Link 01/2021
1	Aprepitant (Emend)FDA Link 01/2021
1	Epidermal Growth Factor (EGF)IBA 05/2020
1	Genetic Markers (Genetic Marker)IBA 12/2019
1	Capecitabine (Xeloda)FDA Link 01/2019
1	Lapatinib (GW572016)FDA Link 01/2019
1	Ado-Trastuzumab EmtansineIBA 01/2019
1	Selective Estrogen Receptor Modulators (SERM)IBA 12/2018
1	130-nm albumin-bound paclitaxelIBA 10/2018
1	AlbuminsIBA 10/2018
1	Epirubicin (Ellence)FDA LinkGeneric 10/2018
1	Docetaxel (Taxotere)FDA Link 09/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016
1	Histone Deacetylase InhibitorsIBA 08/2015
1	olaparibIBA 08/2015
1	Mediator ComplexIBA 07/2015
1	Cisplatin (Platino)FDA LinkGeneric 02/2015
1	Gemcitabine FDA Link 02/2015
1	Collagen Type IV (Type IV Collagen)IBA 09/2014
1	CateninsIBA 09/2014
1	candesartanIBA 12/2011
1	Angiotensin IIIBA 12/2011
1	Hemoglobins (Hemoglobin)IBA 12/2011

Therapy/Procedure

8	Therapeutics 03/2024 - 02/2015
7	Neoadjuvant Therapy 09/2021 - 01/2016
5	Drug Therapy (Chemotherapy) 12/2023 - 02/2015
4	Radiotherapy 03/2023 - 07/2020
3	Adjuvant Chemotherapy 03/2023 - 02/2015
2	Kidney Transplantation 02/2015 - 08/2008
2	Transplantation 08/2008 - 10/2003
1	Cryosurgery 04/2024
1	Local Anesthesia 04/2024
1	Aftercare (After-Treatment) 03/2022
1	Mastectomy (Mammectomy) 11/2016
1	Skin Transplantation (Skin Grafting) 07/2016
1	Lymph Node Excision (Lymph Node Dissection) 01/2016
1	TP protocol 02/2015
1	Combination Drug Therapy (Combination Chemotherapy) 02/2015